Daemonorops draco is a highly valued traditional herbal medicine in Southeast Asia, and its resin is known as the “jewel” of Asian herbal medicine. In recent years, dragon’s blood has attracted more and more attention from the international market, and has been widely recognized by the pharmaceutical and medical circles.
As a super new drug with great potential, dragon’s blood is shining on the international stage with its mysterious pharmacological properties and huge medical value. Dracaena has been used in traditional Asian medicine since ancient times. Its resin is rich in active ingredients such as tannic acid, gentianin, and flavonoids, which give dragon’s blood its powerful properties. Studies have shown that Dracaena not only has antibacterial, anti-inflammatory and hemostatic effects, but also has various pharmacological effects such as anti-oxidation, anti-tumor and immune regulation.
This makes dragon’s blood an ideal choice for treating diseases, especially showing great potential in cancer, cardiovascular and cerebrovascular diseases and immune system disorders. In addition, dragon’s blood has also attracted much attention in the field of cosmetics and skin care products. It has astringent, calming and anti-oxidant effects, can reduce wrinkles, improve skin elasticity and promote wound healing, and has become the focus of many skin care companies. The red pigment of dragon’s blood resin is also widely used in the fashion industry, such as dyes, lipsticks and nail polishes.
Its miraculous effect and natural origin have caused a sensation all over the world, and many countries have rushed to introduce and apply it. After seeing the huge business opportunity of dragon’s blood, some international pharmaceutical companies and research institutes have stepped up research on this herb.
Through research and development, they successfully incorporated dragon’s blood into the field of new drug development and achieved amazing results. Drugs with dragon’s blood as the main ingredient have made breakthroughs in the treatment of leukemia, breast cancer, diabetes and various chronic diseases.
In the international market, the commercialization opportunities of dragon’s blood can not be ignored. With people’s re-awareness and increasing demand for natural herbal medicine and traditional medicine, dragon’s blood has ushered in broad opportunities for development.
Many countries and regions have introduced dragon’s blood products one after another, and continuously expanded the scale of production and sales through export and technical cooperation. Asian countries such as Indonesia, Malaysia, and the Philippines have become major suppliers, while developed countries such as the United States, Europe, and Japan have become major demand markets. Although there are still some challenges in the commercialization of dragon’s blood, its huge medical and commercial value cannot be ignored.
The government, enterprises and research institutions should strengthen cooperation, encourage scientific research and innovation, and promote the wide application of dragon’s blood in the world. At the same time, strengthen the standardized planting, extraction and processing of dragon’s blood to ensure the quality and safety of the product. Only in this way can dracaena dracaena further develop its potential medical and economic value and make greater contributions to human health and well-being.
The glory of dragon’s blood has already begun, and it is jumping onto the international stage, adding a bright color to the traditional herbal medicine culture in Asia. I believe that in the future, dragon’s blood will not only be an Asian gem, but a treasure in the global medical field, allowing more people to benefit from its unique pharmacological properties and the wisdom of traditional herbal medicine.
Post time: Aug-16-2023
